Dr. Grice joined Abide Therapeutics in 2012 as Senior Director of Chemistry and was promoted to Vice President of Chemistry in 2015. In her current role, Dr. Grice leads the medicinal chemistry and CMC efforts for Abide’s portfolio of lead optimization programs and drug candidates in preclinical and clinical development. As one of the first Abide employees, Dr. Grice was instrumental in building the early research team, establishing the initial research programs, collaborations, the chemical library as well as all aspects of operations and laboratory facilities.
Dr. Grice joined Abide Therapeutics in 2012 as Senior Director of Chemistry and was promoted to Vice President of Chemistry in 2015. In her current role, Dr. Grice leads the medicinal chemistry and CMC efforts for Abide’s portfolio of lead optimization programs and drug candidates in preclinical and clinical development. As one of the first Abide employees, Dr. Grice was instrumental in building the early research team, establishing the initial research programs, collaborations, the chemical library as well as all aspects of operations and laboratory facilities.